Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Monday, Immutep Ltd (YP1A:FRA) closed at 1.69, 9.03% above its 52-week low of 1.55, set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.69 |
---|---|
High | 1.69 |
Low | 1.69 |
Bid | -- |
Offer | -- |
Previous close | 1.69 |
Average volume | 1.52k |
---|---|
Shares outstanding | 145.26m |
Free float | 141.38m |
P/E (TTM) | -- |
Market cap | 288.52m USD |
EPS (TTM) | -0.2625 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 08:17 BST.
More ▼